Cardiac Arrest Treatment Market
Cardiac Arrest Treatment Market Size, Share & Trends Analysis Report By Product Type (External Defibrillators, Implantable Devices, Emergency Drugs, Monitoring Systems), By Treatment Type (Pharmacological Treatment, Device-Based Treatment, Post-Cardiac Arrest Care), By Application (Out-of-Hospital Cardiac Arrest (OHCA), In-Hospital Cardiac Arrest (IHCA)), By End-Use Industry (Hospitals & Cardiac Centers, Emergency Medical Services (EMS), Public Access Settings, Home Care Settings), and Forecast Period (2026–2035)
Industry Overview
Cardiac arrest treatment market was valued at $13.5 billion in 2025 and is projected to reach $23.0 billion by 2035, expanding at a CAGR of 5.8% during the forecast period. The market comprises critical, life-saving interventions such as defibrillation, emergency pharmacological therapies, and post-resuscitation care. The rising incidence of cardiovascular diseases, coupled with a rapidly aging global population, is significantly increasing the number of cardiac arrest cases worldwide. In response, healthcare systems are focusing on improving emergency response capabilities and treatment outcomes. Technological advancements in automated external defibrillators (AEDs), implantable cardioverter defibrillators (ICDs), and advanced patient monitoring systems are playing a crucial role in enhancing survival rates and reducing complications associated with sudden cardiac arrest. These innovations are enabling faster diagnosis, timely intervention, and improved patient management across both hospital and out-of-hospital settings.
Market growth is further driven by continuous innovation and strategic initiatives by leading industry players. In November 2025, Medtronic plc reported positive real-world outcomes for its Aurora EV-ICD system through the Enlighten post-market study and LEADR pivotal trial, demonstrating strong anti-tachycardia pacing performance, effective defibrillation, and low complication rates across diverse patient populations. The Omnia Secure defibrillation lead also exhibited robust long-term safety and reliability over three years, reinforcing the importance of implantable solutions in preventing sudden cardiac arrest. Additionally, in February 2024, ZOLL Medical Corporation announced that its ZOLL AED 3 defibrillator received CE marking under the European Union Medical Device Regulation (EU MDR), confirming compliance with stringent safety and quality standards. This milestone strengthens the company’s position in the external defibrillator segment and highlights the industry’s growing emphasis on improving emergency preparedness and patient outcomes globally.
Market Dynamics
Smart Connected Care Ecosystems Strengthen Device-Based Cardiac Arrest Treatment
Device-based treatment continues to dominate the cardiac arrest treatment market due to the essential role of defibrillators and implantable devices in restoring normal cardiac rhythm during emergencies. The increasing integration of digital technologies with medical devices is further enhancing treatment efficiency and response time. In March 2026, Stryker Corporation introduced its Smart Hospital Platform, a connected ecosystem designed to integrate hospital devices, clinical data, and care teams. The platform leverages artificial intelligence, virtual care, and ambient monitoring to improve real-time clinical decision-making. Although not a direct treatment solution, it significantly strengthens emergency response infrastructure by enabling faster coordination during critical events such as cardiac arrest. Additionally, improved data connectivity and workflow automation enhance patient monitoring and care continuity across hospital settings. These advancements reinforce the importance of device-based ecosystems in supporting life-saving interventions.
Public Access AED Expansion Driving Dominance of External Defibrillators in Cardiac Arrest Treatment Market
External defibrillators continue to lead the product type segment, driven by their critical role in delivering immediate life-saving intervention during sudden cardiac arrest. Their increasing deployment across public locations such as airports, railway stations, offices, and shopping centers is significantly improving survival outcomes. The growing emphasis on rapid response systems and bystander intervention has further accelerated adoption globally. In December 2025, U.S. lawmakers introduced the Public Access to Defibrillation in Transportation Facilities Act, aimed at expanding the availability of automated external defibrillators (AEDs) across major transportation hubs. This initiative highlights the rising focus on strengthening emergency preparedness infrastructure. Additionally, technological advancements such as user-friendly interfaces and real-time guidance features are enhancing AED usability among non-medical personnel. As a result, external defibrillators are becoming a cornerstone of public health safety strategies.
Market Segmentation
- Based on product type, the market is segmented into external defibrillators, implantable devices, emergency drugs, and monitoring systems.
- Based on treatment type, the market is segmented into pharmacological treatment, device-based treatment, and post-cardiac arrest care.
- Based on application, the market is segmented into out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA).
- Based on end-user, the market is segmented into hospitals & cardiac centers, emergency medical services (EMS), public access settings, and home care settings.
Expanding Public AED Networks Transform Emergency Response for Out-of-Hospital Cardiac Arrest
Out-of-hospital cardiac arrest (OHCA) represents the largest share of cardiac arrest cases, significantly driving demand for portable defibrillators and emergency medical services. The growing emphasis on rapid response systems and early defibrillation is improving survival outcomes in public settings. Governments and private organizations are increasingly investing in automated external defibrillator (AED) deployment across high-traffic locations. In October 2025, Koninklijke Philips N.V. partnered with Securitas and Medic Assist to integrate AEDs into security operations, enabling faster on-site emergency response. The initiative focuses on creating “heart-safe” workplaces and public environments through continuous monitoring and maintenance of connected AED systems. Trained personnel can deliver immediate intervention during cardiac emergencies, reducing response time significantly. Such collaborations are strengthening pre-hospital care infrastructure and enhancing accessibility to life-saving devices. As a result, increasing AED penetration and public awareness are playing a crucial role in advancing the cardiac arrest treatment market.
Strengthening First Response Networks: Hospitals and EMS Drive Life-Saving Cardiac Care Expansion
Hospitals and emergency medical services (EMS) continue to dominate the end-user segment due to their critical role in managing high volumes of cardiac emergencies and delivering immediate life-saving interventions. These institutions form the backbone of cardiac arrest treatment through rapid response systems, advanced critical care infrastructure, and continuous workforce training. Increasing investments in emergency preparedness and resuscitation capabilities are further reinforcing their leadership in the market. In February 2026, Meenakshi Mission Hospital & Research Centre trained over 1,500 police personnel in essential life-saving techniques, including CPR, basic life support (BLS), and automated external defibrillator (AED) usage. Conducted in collaboration with the Madurai district police, this initiative aims to enhance first-response efficiency during sudden cardiac arrest cases. Such programs highlight the growing emphasis on expanding emergency response networks beyond traditional healthcare settings. As a result, hospitals and EMS providers are playing a pivotal role in improving survival outcomes and strengthening the overall cardiac arrest care ecosystem.
Regional Outlook
The global cardiac arrest treatment market is further divided by region, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America is the leading region in the market
North America leads the cardiac arrest treatment market, supported by advanced healthcare infrastructure and high adoption of innovative cardiac technologies. The region benefits from strong emergency medical services, widespread availability of defibrillators, and well-established critical care systems. In August 2025, GE HealthCare Technologies Inc. showcased its integrated cardiology care pathway solutions at ESC 2025, highlighting AI-enabled platforms such as ViewPoint EchoPilot and CardIQ Suite. These solutions are designed to enhance clinical decision-making, streamline workflows, and improve diagnostic accuracy. The innovations focus on early detection and management of cardiovascular diseases, which account for over 20.5 million causalities globally. Although primarily centered on diagnostics and care coordination, these advancements play a crucial role in improving emergency response readiness. Enhanced monitoring and faster diagnosis contribute to timely interventions in cardiac emergencies. As a result, such developments indirectly strengthen the cardiac arrest treatment market by improving survival outcomes.
Market Players Outlook
The major companies operating in the global cardiac arrest treatment market include Pfizer Inc., Abbott Laboratories, Medtronic plc, Stryker Corporation, and Koninklijke Philips N.V., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In February 2026, Abbott announced that the US FDA approved its next?generation CardioMEMS HERO remote pulmonary artery pressure reader, a device designed to help clinicians monitor heart failure progression more effectively by enabling daily pressure measurements and early intervention, supporting improved patient outcomes and reducing hospitalizations.
- In January 2024, Mindray showcased its latest smart hospital innovations at Arab Health 2024 in Dubai, including the new BeneHeart DX defibrillator/monitor for advanced cardiac emergency care reinforcing its presence in the cardiac arrest treatment and life?support market.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global cardiac arrest treatment market
- Based on the availability of data, information related to new Protections and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Cardiac Arrest Treatment Market Sales Analysis – Product Type | Treatment | Application | End-User ($ Million)
- Cardiac Arrest Treatment Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach Analytics
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Cardiac Arrest Treatment Market Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers of Cardiac Arrest Treatment Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Cardiac Arrest Treatment Market: Impact Analysis
- Market Opportunities
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Cardiac Arrest Treatment Market Revenue and Share by Manufacturers
- Cardiac Arrest Treatment Type Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Pfizer Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Abbott Laboratories
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Medtronic plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Stryker Corporation
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- GE HealthCare Technologies Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Koninklijke Philips N.V.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Pfizer Inc.
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Cardiac Arrest Treatment Market Sales Analysis By Product Type ($ Million)
- External Defibrillators
- Implantable Devices
- Emergency Drugs
- Monitoring Systems
- Cardiac Arrest Treatment Market Sales Analysis By Treatment ($ Million)
- Pharmacological Treatment
- Device-Based Treatment
- Post-Cardiac Arrest Care
- Cardiac Arrest Treatment Market Sales Analysis By Application ($ Million)
- Out-of-Hospital Cardiac Arrest (OHCA)
- In-Hospital Cardiac Arrest (IHCA)
- Cardiac Arrest Treatment Market Sales Analysis By End User ($ Million)
- Hospitals & Cardiac Centers
- Emergency Medical Services (EMS)
- Public Access Settings
- Home Care Settings
- Regional Analysis
- North American Cardiac Arrest Treatment Market Sales Analysis – Product Type | Treatment | Application | End-Users| Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Cardiac Arrest Treatment Market Sales Analysis – Product Type | Treatment | Application | End-Users| Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Cardiac Arrest Treatment Market Sales Analysis – Product Type | Treatment | Application | End-User| Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the Cardiac Arrest Treatment Market Sales Analysis – Product Type | Treatment | Application | End-Users| Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ambu A/S
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Amneal Pharmaceuticals Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton, Dickinson and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bexen Cardio
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BIOTRONIK SE & Co. KG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boston Scientific Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cardiac Science Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- CU Medical Systems Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Defibtech LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Drägerwerk AG & Co. KGaA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fukuda Denshi Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GE HealthCare Technologies Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hikma Pharmaceuticals plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Koninklijke Philips N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- MicroPort Scientific Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Mindray Medical International Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nihon Kohden Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Otsuka Pharmaceutical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Schiller AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Stryker Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Weinmann Emergency Medical Technology GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ZOLL Medical Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
1. Global Cardiac Arrest Treatment Market Research and Analysis By Product Type, 2025-2035 ($ Million)
2. Global External Defibrillators Market Research and Analysis By Region, 2025-2035 ($ Million)
3. Global Implantable Devices Market Research and Analysis By Region, 2025-2035 ($ Million)
4. Global Emergency Drugs Market Research and Analysis By Region, 2025-2035 ($ Million)
5. Global Monitoring Systems Treatment Market Research and Analysis By Region, 2025-2035 ($ Million)
6. Global Cardiac Arrest Treatment Market Research and Analysis By Treatment, 2025-2035 ($ Million)
7. Global Pharmacological Cardiac Arrest Treatment Market Research and Analysis By Region, 2025-2035 ($ Million)
8. Global Device-Based Cardiac Arrest Treatment Market Research and Analysis By Region, 2025-2035 ($ Million)
9. Global Post-Cardiac Arrest Care Treatment Market Research and Analysis By Region, 2025-2035 ($ Million)
10. Global Cardiac Arrest Treatment Market Research and Analysis By Application, 2025-2035 ($ Million)
11. Global Out-of-Hospital Cardiac Arrest (OHCA) Treatment Market Research and Analysis By Region, 2025-2035 ($ Million)
12. Global In-Hospital Cardiac Arrest (IHCA) Treatment Market Research and Analysis By Region, 2025-2035 ($ Million)
13. Global Cardiac Arrest Treatment Market Research and Analysis By End User, 2025-2035 ($ Million)
14. Global Cardiac Arrest Treatment For Hospitals & Cardiac Centers Market Research and Analysis By Region, 2025-2035 ($ Million)
15. Global Cardiac Arrest Treatment For Emergency Medical Services (EMS) Market Research and Analysis By Region, 2025-2035 ($ Million)
16. Global Cardiac Arrest Treatment For Public Access Settings Market Research and Analysis By Region, 2025-2035 ($ Million)
17. Global Cardiac Arrest Treatment For Home Care Settings Market Research and Analysis By Region, 2025-2035 ($ Million)
18. Global Cardiac Arrest Treatment Market Research and Analysis By Region, 2025-2035 ($ Million)
19. North American Cardiac Arrest Treatment Market Research and Analysis By Country, 2025-2035 ($ Million)
20. North American Cardiac Arrest Treatment Market Research and Analysis By Product Type, 2025-2035 ($ Million)
21. North American Cardiac Arrest Treatment Market Research and Analysis By Treatment, 2025-2035 ($ Million)
22. North American Cardiac Arrest Treatment Market Research and Analysis By Application, 2025-2035 ($ Million)
23. North American Cardiac Arrest Treatment Market Research and Analysis By End User, 2025-2035 ($ Million)
24. European Cardiac Arrest Treatment Market Research and Analysis By Country, 2025-2035 ($ Million)
25. European Cardiac Arrest Treatment Market Research and Analysis By Product Type, 2025-2035 ($ Million)
26. European Cardiac Arrest Treatment Market Research and Analysis By Treatment, 2025-2035 ($ Million)
27. European Cardiac Arrest Treatment Market Research and Analysis By Application, 2025-2035 ($ Million)
28. European Cardiac Arrest Treatment Market Research and Analysis By End User, 2025-2035 ($ Million)
29. Asia-Pacific Cardiac Arrest Treatment Market Research and Analysis By Country, 2025-2035 ($ Million)
30. Asia-Pacific Cardiac Arrest Treatment Market Research and Analysis By Product Type, 2025-2035 ($ Million)
31. Asia-Pacific Cardiac Arrest Treatment Market Research and Analysis By Treatment, 2025-2035 ($ Million)
32. Asia-Pacific Cardiac Arrest Treatment Market Research and Analysis By Application, 2025-2035 ($ Million)
33. Asia-Pacific Cardiac Arrest Treatment Market Research and Analysis By End User, 2025-2035 ($ Million)
34. Rest of the World Cardiac Arrest Treatment Market Research and Analysis By Country, 2025-2035 ($ Million)
35. Rest of the World Cardiac Arrest Treatment Market Research and Analysis By Product Type, 2025-2035 ($ Million)
36. Rest of the World Cardiac Arrest Treatment Market Research and Analysis By Treatment, 2025-2035 ($ Million)
37. Rest of the World Cardiac Arrest Treatment Market Research and Analysis By Application, 2025-2035 ($ Million)
38. Rest of the World Cardiac Arrest Treatment Market Research and Analysis By End User, 2025-2035 ($ Million)
1. Global Cardiac Arrest Treatment Market Research and Analysis By Product Type, 2025 Vs 2035 ($ Million)
2. Global External Defibrillators Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
3. Global Implantable Devices Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
4. Global Emergency Drugs Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
5. Global Monitoring Systems Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
6. Global Cardiac Arrest Treatment Market Research and Analysis By Treatment, 2025 Vs 2035 ($ Million)
7. Global Pharmacological Cardiac Arrest Treatment Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
8. Global Device-Based Cardiac Arrest Treatment Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
9. Global Post-Cardiac Arrest Care Treatment Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
10. Global Cardiac Arrest Treatment Market Research and Analysis By Application, 2025 Vs 2035 ($ Million)
11. Global Out-of-Hospital Cardiac Arrest (OHCA) Treatment Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
12. Global In-Hospital Cardiac Arrest (IHCA) Treatment Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
13. Global Cardiac Arrest Treatment Market Research and Analysis By End User, 2025 Vs 2035 ($ Million)
14. Global Cardiac Arrest Treatment For Hospitals & Cardiac Centers Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
15. Global Cardiac Arrest Treatment For Emergency Medical Services (EMS) Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
16. Global Cardiac Arrest Treatment For Public Access Settings Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
17. Global Cardiac Arrest Treatment For Home Care Settings Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
18. US Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
19. Canada Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
20. UK Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
21. France Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
22. Germany Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
23. Italy Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
24. Spain Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
25. Russia Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
26. Rest of Europe Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
27. India Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
28. China Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
29. Japan Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
30. South Korea Cardiac Arrest Treatment, 2025-2035 ($ Million)
31. Australia and New Zealand Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
32. ASEAN Economies CARDIAC ARREST TREATMENT Market Size, 2025-2035 ($ Million)
33. Rest of Asia-Pacific Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
34. Latin America Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
35. Middle East and Africa Cardiac Arrest Treatment Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
